SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,271.12 |
| Enterprise Value ($M) | 2,777.52 |
| Book Value ($M) | 684.23 |
| Book Value / Share | 4.95 |
| Price / Book | 3.32 |
| NCAV ($M) | -703.56 |
| NCAV / Share | -5.10 |
| Price / NCAV | -3.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.10 |
| Return on Assets (ROA) | -0.15 |
| Return on Equity (ROE) | -0.29 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.84 |
| Current Ratio | 0.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 185.71 |
| Assets | 1,573.50 |
| Liabilities | 889.27 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3.55 |
| Operating Income | -601.08 |
| Net Income | -599.49 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -462.85 |
| Cash from Investing | -420.07 |
| Cash from Financing | 870.52 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 5.10 | 16.34 | |
| 13G/A | BlackRock, Inc. | 13.80 | 42.92 | |
| 13D | Sarepta Therapeutics, Inc. | 9.50 | ||
| 13G/A | Avoro Capital Advisors LLC | 9.60 | 35.32 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 262,269 | 1,159,881 | 22.61 | |
| 293,207 | 1,273,004 | 23.03 | |
| 236,740 | 1,172,568 | 20.19 | |
| 323,183 | 1,416,791 | 22.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APLS – Apellis Pharmaceuticals, Inc. | ARQT – Arcutis Biotherapeutics, Inc. |
| ARVN – Arvinas, Inc. | ASMB – Assembly Biosciences, Inc. |
| ATRA – Atara Biotherapeutics, Inc. |